You've got mail: erj@lumc.nl Sterk P.J., Rabe K.F. Eur Respir J 2003; 21: 1-2 | |
Modulatory role of tachykinin NK1 receptor in cholinergic contraction of mouse trachea Tournoy K.G., De Swert K.O., Leclere P.G., Lefebvre R.A., Pauwels R.A., Joos G.F. Eur Respir J 2003; 21: 3-10 | |
T-helper 1 cells induce alveolitis but do not lead to pulmonary fibrosis in mice Irifune K., Yokoyama A., Kohno N., Sakai K., Hiwada K. Eur Respir J 2003; 21: 11-18 | |
Endogenous endothelins and nitric oxide in hypoxic pulmonary vasoconstriction Hubloue I., Biarent D., Kafi S. A., Bejjani G., Kerbaul F., Naeije R., Leeman M. Eur Respir J 2003; 21: 19-24 | |
Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis Nizankowska-Mogil... E., Adamek L., Grzanka P., Domagala T.B., Sanak M., Krzanowski M., Szczeklik A. Eur Respir J 2003; 21: 25-30 | |
Single arterial occlusion to locate resistance in patients with pulmonary hypertension Fesler P., Pagnamenta A., Vachiery J-L., Brimioulle S., Abdel Kafi S., Boonstra A., Delcroix M., Channick R.N., Rubin L.J., Naeije R. Eur Respir J 2003; 21: 31-36 | |
Airway surface pH in subjects with cystic fibrosis McShane D., Davies J.C., Davies M.G., Bush A., Geddes D.M., Alton E.W.F.W. Eur Respir J 2003; 21: 37-42 | |
Nasal nitric oxide measurements for the screening of primary ciliary dyskinesia Wodehouse T., Kharitonov S.A., Mackay I.S., Barnes P.J., Wilson R., Cole P.J. Eur Respir J 2003; 21: 43-47 | |
Effect of oxygen on breath markers of oxidative stress Phillips M., Cataneo R.N., Greenberg J., Grodman R., Gunawardena R., Naidu A. Eur Respir J 2003; 21: 48-51 | |
Markers of activity in clinically recovered human leukocyte antigen-DR17-positive sarcoidosis patients Planck A., Eklund A., Grunewald J. Eur Respir J 2003; 21: 52-57 | |
Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients Hernandez C., Casas A., Escarrabill J., Alonso J., Puig-Junoy J., Farrero E., Vilagut G., Collvinent B., Rodriguez-Roisin R., Roca J., and partners of t... Eur Respir J 2003; 21: 58-67 | |
Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations Jones P.W., Willits L.R., Burge P.S., Calverley P.M.A. Eur Respir J 2003; 21: 68-73 | |
Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease Szafranski W., Cukier A., Ramirez A., Menga G., Sansores R., Nahabedian S., Peterson S., Olsson H. Eur Respir J 2003; 21: 74-81 | |
Bronchodilation test in COPD: effect of inspiratory manoeuvre preceding forced expiration Santus P., Pecchiari M., Carlucci P., Boveri B., Di Marco F., Castagna F., Centanni S. Eur Respir J 2003; 21: 82-85 | |
Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD Di Marco F., Milic-Emili J., Boveri B., Carlucci P., Santus P., Casanova F., Cazzola M., Centanni S. Eur Respir J 2003; 21: 86-94 | |
The role of concomitant respiratory diseases on the rate of decline in FEV1 among adult asthmatics Sherrill D., Guerra S., Bobadilla A., Barbee R. Eur Respir J 2003; 21: 95-10 | |
Use of anti-inflammatory therapy and asthma mortality in Japan Suissa S., Ernst P. Eur Respir J 2003; 21: 101-104 | |
Socioeconomical conditions as risk factors for bronchial asthma in children aged 4-5 yrs Lindbaek M., Wefring K.W., Grangard E.H., Ovsthus K. Eur Respir J 2003; 21: 105-108 | |
Evaluation of an individualised asthma programme directed at behavioural change Put C., van den Bergh O., Lemaigre V., Demedts M., Verleden G. Eur Respir J 2003; 21: 109-115 | |
Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1-yr retrospective study Schramm B., Ehlken B., Smala A., Quednau K., Berger K., Nowak D. Eur Respir J 2003; 21: 116-122 | |
Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone Baumgartner R.A., Martinez G., Edelman J.M., Rodriguez Gomez G.G., Bernstein M., Bird S., Angner R., Polis A., Dass S.B., Lu S., Reiss T.F. Eur Respir J 2003; 21: 123-128 | |
Monitoring the quality of laboratories and the prevalence of resistance to antituberculosis drugs: Italy, 1998-2000 Migliori G.B., Centis R., Fattorini L., Besozzi G., Saltini C., Orefici G., Piersimoni C., Gori A., Cassone A., the Italian Multi... Eur Respir J 2003; 21: 129-134 | |
Effectiveness of oral moxifloxacin in standard first-line therapy in community-acquired pneumonia Torres A., Muir J-F., Corris P., Kubin R., Duprat-Lomon I., Sagnier P-P., Hoffken G. Eur Respir J 2003; 21: 135-143 | |
Bronchoalveolar lavage fluid findings in children with hypersensitivity pneumonitis Ratjen F., Costabel U., Griese M., Paul K. Eur Respir J 2003; 21: 144-148 | |
Urinary leukotriene E4 in preschool children with acute clinical viral wheeze Oommen A., Grigg J. Eur Respir J 2003; 21: 149-154 | |
Pulmonary arterial hypertension in children Widlitz A., Barst R.J. Eur Respir J 2003; 21: 155-176 | |
Biomarkers of lipid peroxidation, airway inflammation and asthma Wood L.G., Gibson P.G., Garg M.L. Eur Respir J 2003; 21: 177-186 | |
Acute interstitial pneumonia: report of a series Bonaccorsi A., Cancellieri A., Chilosi M., Trisolini R., Boaron M., Crimi N., Poletti V. Eur Respir J 2003; 21: 187-191 | |
Epoprostenol therapy for primary pulmonary hypertension after rejection of a single donor lung Roeleveld R.J., Vonk Noordegraaf A., van der Bij W., Postmus P.E., Boonstra A. Eur Respir J 2003; 21: 192-194 | |
Exhaled breath temperature in asthma Paredi P., Kharitonov S.A., Barnes P.J. Eur Respir J 2003; 21: 195 | |
From the Authors Piacentini G.L., Bodini A., Zerman L., Costella S., Zanolla L., Peroni D.G., Boner A.L. Eur Respir J 2003; 21: 196 | |
Exhaled carbon monoxide in lung disease Paredi P., Kharitonov S.A., Barnes P.J. Eur Respir J 2003; 21: 197 | |
From the Authors Zetterquist W., Lundberg J.O.N., Alving K. Eur Respir J 2003; 21: 197-198 | |
Benjamin Burrows, MD, 1927-2002 Postma D.S., Pride N., Viegi G. Eur Respir J 2003; 21: 200 | |